-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.EUR↓
Firmenname
Mesoblast Limited
Marktkapitalisierung
942.796.544 (+- 11%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.042.593.088 oder 843.000.000
Mitarbeiter
90 (+- 14%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
102 oder 77 Mitarbeiter
EBITDA -78.815.000
Buchwert 4.42
Mesoblast Ltd ADR underperformed den DAX um -76 % vom 29.04.2020 bis 07.07.2021
Dir gefallen die Informationen zu Mesoblast Ltd ADR?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Mesoblast Ltd ADR?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Mesoblast Ltd ADR?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Mesoblast Ltd ADR?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
81 News & Informationen zur Mesoblast Ltd ADR Aktie
ASX Close: Friday rebound seals weekly win
An end-of-week rally helped the share market log a second straight weekly…
Weekly ASX small cap wrap: Bulls are raking in money
Weekly ASX small cap wrap: Bulls are raking in money
ASX Update: Back above 7500 as miners, health rally
Post-dividend rebounds in BHP and CSL helped the share market rise for…
Australian shares end at 2-week low as BHP tumbles on ex-div trade
BHP Group, the world's biggest miner, was the top loser on the benchmark with a near 7% tumble, as it traded ex-dividend. It had declared a final dividend of $2 per share last month.
BHP : Australian shares end at 2-week low as BHP tumbles on ex-div trade
Australian shares closed at a two-week
low on Thursday, dragged by a steep drop in mining giant BHP
Group after they traded without access to the next dividend,
while a slump in iron ore prices… | September 2, 2021
ASX Close: September blues as dividends weigh
Rivers of gold pouring into shareholders’ accounts in the form of dividend…
ASX Update: Dividends weigh as index hits two-week low
Shares retreated for a second day following soft leads from Wall Street…
Why the Mesoblast (ASX:MSB) share price is down 21% this week
Shares in Mesoblast Limited (ASX: MSB) have taken a 21% dive this week following the release of its FY21 results. Here are the details.
Why the Mesoblast (ASX:MSB) share price is down 21% this week
Shares in Mesoblast Limited (ASX: MSB) have taken a 21% dive this week following the release of its FY21 results. Here are the details.
Why the Mesoblast (ASX:MSB) share price is down 21% this week
Shares in Mesoblast Limited (ASX: MSB) have taken a 21% dive this week following the release of its FY21 results. Here are the details.
Futures Pointing To Initial Strength On Wall Street
The major U.S. index futures are currently pointing to a higher open on Wednesday, with stocks likely to move back to the upside after ending the previous session modestly lower.
Futures Rise Toward Fresh Record High As PMIs Confirm Global Economy Slowing
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…
Brickell Biotech Expands Leadership Team, Appointing Dr.
Dr. Luchi brings over 20 years of immunotherapeutic and drug development experience and will lead Brickell’s clinical development strategy and medical…
Pre-market Movers: FCUV, BXRX, LAIX, VALN…
The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.45 A.M. EDT)..
Australia shares trim losses on better-than-expected GDP data
The S&P/ASX 200 index closed 0.1% lower at 7,527.1, recovering from a 1% drop earlier in the session, after data showed that Australia's second-quarter GDP rose 0.7%, bucking analysts' worst fears of a negative outcome.
Asian Shares Rise Despite Signs Of Slowing Growth
(RTTNews) – Asian stocks rose broadly on Wednesday in spite of signs that the region's factory activity lost momentum in August due to a resurgenc…
Here are the top ASX large cap movers for Wednesday
Here are the top ASX large cap movers for Wednesday
Rise and Shine: What you need to know before the ASX opens
Will Andrew Forrest become the King of Nickel, three pre-IPO plays at becoming green hydrogen giants and some ASX ‘deep value’ picks from Katana.
Why Mesoblast Stock Is Plunging After Q4 Earnings Report?
Mesoblast Limited (NASDAQ: MESO) shares dived on Tuesday as the FDA raised more questions around its flagship drug candidate, and its&nb…
Profit Taking May Lead To Initial Weakness On Wall Street
The major U.S. index futures are currently pointing to a modestly lower open on Tuesday, with stocks likely to give back ground after ending the previous session mostly higher.
Tech, healthcare help Australia shares notch 2-week closing high
Australian stocks took cues from solid current account data and an upbeat New York session overnight, Jeffrey Halley, a market analyst at OANDA, said in a note.
ASX sets record of 11 months of gains
Shares have had the most consecutive months of gains in ASX 200 history after the last day of August ensured a streak of 11.
Mesoblast Shares Tumble as Losses Widen (ASX:MSB)
The MSB share price down 14%. The Mesoblast (ASX:MSB) posted a FY21 net loss of $98.8 million as the FDA asks for further trials of MSB’s emergency COVID treatment…
Closing Bell: Tech pushes ASX to another positive day
Closing Bell: Tech pushes ASX to another positive day
ASX Close: Win streak hits 11 months as tech surges
End-of-month buying and positive signs for tomorrow’s economic growth figures helped lift…
Mesoblast EPS beats by $0.38 (NASDAQ:MESO)
Mesoblast (MESO): FY GAAP EPS of -$0.16 beats by $0.38.Royalty revenues on sales of TEMCELL® HS Inj
Asian Markets Mostly Lower
Asian stock markets are trading mostly lower on Tuesday, ignoring the broadly positive cues from Wall Street overnight, amid the uncertainty about the pace of global economic recovery due to surging coronvirus cases in the region and the continuing regulatory clampdown in China.
ASX Update: Second straight rise as tech stocks rally
The share market firmed on the last session of the month as…
ASX Small Cap Lunch Wrap: Who’s swimming against the tide today?
ASX Small Cap Lunch Wrap: Who’s swimming against the tide today?
10 at 10: These ASX stocks are the most hotly contested for amongst investors this morning
10 at 10: These ASX stocks are the most hotly contested for amongst investors this morning
Mesoblast (ASX:MSB) shares retreat on FY21 report
Mesoblast (ASX:MSB) has tumbled on the ASX today after flagging a wider year-on-year loss for the 2021 financial year.
Mesoblast : Management Team
Management Team
Mesoblast has a highly experienced management team made up of individuals who have held senior positions in international pharmaceutical and… | August 28, 2021
ASX Health Stocks: Dimerix commences Phase 3 trial, while IDT scoots 10pc after restoring profit
ASX biotech stock Dimerix (ASX:DXB) announced that it has commenced ACTION3, a Phase III study in patients with focal segmental glomerulosclerosis (FSGS).
Telix Progresses Novel Lung and Ovarian Cancer Theranostic APOMAB®
Telix Progresses Novel Lung and Ovarian Cancer Theranostic APOMAB®
GlobeNewswire
August 17, 2021
MELBOURNE, Australia and ADELAIDE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces it has extended its previously announced partnership with AusHealth Corporate Pty Ltd (‘AusHealth’) relating to APOMAB®, a novel…
Here are the top ASX large cap movers for Tuesday
Here are the top ASX large cap movers for Tuesday
ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc
ASX medical imaging specialist, EMVision (ASX:EMV), rose by 12% after announcing that 1st Gen portable brain scanner has now been completed.
Short and Caught: It appears investors are responding to takeover bids… by shorting the targets’ rivals
ASX investors have responded to takeover bids of Afterpay and Huon by shorting their rivals Zip (ASX:Z1P) and Tassal (ASX:TGL).
Why Emerge Gaming, Imugene, Mesoblast, & Nick Scali shares are dropping
Mesoblast limited (ASX:MSB) and Nick Scali Limited (ASX:NCK) shares are two of four that are dropping on Thursday…
ASX Update: Banking gains steer market to fresh high